Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alzheimer's disease

Executive Summary

Researchers at Athena Neurosciences identify the beta-amyloid protein, which causes plaque deposits in the brain of Alzheimer's patients and is the precursor to the protease nexin II protein. A study published in the Sept. 14 issue of Nature suggests that the amyloid plaque deposits may be the result of the incorrect metabolic processing of the beta-amyloid protein. Based in South San Francisco, California, Athena Neurosciences is developing diagnostics and therapeutics for Alzheimer's disease.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS016234

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel